Hex:2 HexNAc:2 NeuAc:2

Taxonomy

• Homo sapiens (Human)
• Bos taurus (Bovine)
• Equus caballus (Domestic horse)
• Mus musculus (House mouse)
• Oryctolagus cuniculus (Rabbit)
• Rattus norvegicus (Norway rat)
• Sus scrofa (Pig)
• Collocalia sp (Glossy swiftlet)
• Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)

Protein

• Angiotensin-converting enzyme 2 / Homo sapiens    Q9BYF1
• Chondroitin sulfate proteoglycan / Homo sapiens    
• Choriogonadotropin - alpha and beta chains / Homo sapiens    P0DN86    P01215
• Choriogonadotropin beta chain / Homo sapiens    P0DN86
• Coagulation factor IX / Homo sapiens    P00740
• Glycocalicin / Homo sapiens    P07359
• Hemopexin / Homo sapiens    P02790
• Immunoglobulin gamma-3 (anti-GDob1 allotype G3m(g) / monoclonal) / Homo sapiens    P01860
• Immunoglobulin gamma-3 (anti-GDob1 allotype G3m(s) / monoclonal) / Homo sapiens    P01860
• Insulin-like growth factor II / Homo sapiens    P01344
• Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens    Q14624
• Leukosialin (cd43) / Homo sapiens    P16150
• Matrix metalloproteinase-9 / Homo sapiens    P14780
• Muc1 fusion protein / Homo sapiens    
• Mucin-1 / Homo sapiens    P15941
• P-selectin glycoprotein ligand (psgl-1) / Homo sapiens    Q14242
• Plasma protease c1 inhibitor / Homo sapiens    P05155
• Proheparin-binding EGF-like growth factor / Homo sapiens    Q99075
• Prostaglandin-h2 d-isomerase / Homo sapiens    P41222
• Protein heg homolog 1 / Homo sapiens    Q9ULI3
• Protein YIPF3 / Homo sapiens    Q9GZM5
• Proteoglycan / Homo sapiens    
• Receptor-type tyrosine-protein phosphatase C / Homo sapiens    P08575
• Recombinant Mucin-1 Muc1f (delta tr) / Homo sapiens    P15941
• Recombinant Mucin-1 Muc1f/2tr / Homo sapiens    P15941    Q02817
• Recombinant Mucin-1 Muc1f/5actr / Homo sapiens    P15941    P98088
• Recombinant Mucin-1 Muc1f/5btr / Homo sapiens    P15941    Q9HC84
• Uncharacterized protein / Homo sapiens    
• Uncharacterized protein / Homo sapiens    
• Uncharacterized protein from Urine / Homo sapiens    
• Unspecified mucin / Homo sapiens    
• Urine glycopeptide / Homo sapiens    
• Alpha-2-hs-glycoprotein / Bos taurus    P12763
• Kappa casein / Bos taurus    P02668
• Choriogonadotropin beta chain / Equus caballus    P08751
• Epiglycanin / Mus musculus    D9N008
• Glycophorin / Mus musculus    P14220
• Uncharacterized protein / Mus musculus    
• Uncharacterized protein / Mus musculus    
• Uncharacterized protein / Mus musculus    
• Brain non dialyzable glycopeptide / Oryctolagus cuniculus    
• Asgp-1 / Rattus norvegicus    
• Major membrane glycoprotein - MII2 / Rattus norvegicus    
• Sialoglycoprotein (rspg-4) / Rattus norvegicus    
• Uncharacterized protein from Liver / Rattus norvegicus    
• Uncharacterized proteoglycan / Rattus norvegicus    
• Mucin / Sus scrofa    
• Mucin / Collocalia sp    
• Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)    P0DTC2
• Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)    P0DTC2
• Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)    P0DTC2

Source

• Amniotic Fluid (UBERON_0000173)  
• Aorta (UBERON_0000947)  
• Blood (UBERON_0000178)  
• Blood Plasma (UBERON_0001969)  
• Blood Serum (UBERON_0001977)  
• Bone Marrow (UBERON_0002371)  
• Brain (UBERON_0000955)  
• Colon (UBERON_0001155)   Caco-2 (CVCL_0025)  
• Colonic Mucosa (UBERON_0000317)   HT29-16E (CVCL_C763)  
• Liver (UBERON_0002107)   AH66-TC (CVCL_4368)   Plasma Membrane (GO_0005886)  
• Liver (UBERON_0002107)   Zajdela-Hepatoma (CVCL_1D00)   Cell Surface (GO_0009986)  
• Lymph Node (UBERON_0000029)   CCRF-HSB-2 (CVCL_1859)  
• Mammary Gland (UBERON_0001911)   HBL-100 (CVCL_4362)  
• Mammary Gland (UBERON_0001911)   MDA-MB-231 (CVCL_0062)  
• Mammary Gland (UBERON_0001911)   MTSV1-7 (CVCL_8645)  
• Mammary Gland (UBERON_0001911)   T-47D (CVCL_0553)  
• Mammary Gland (UBERON_0001911)   TA3/Ha (CVCL_4321)  
• Mammary Gland (UBERON_0001911)   ZR-75-1 (CVCL_0588)  
• Mammary Gland (UBERON_0001911)  
• Milk (UBERON_0001913)  
• Placenta (UBERON_0001987)   BeWo (CVCL_0044)   Epithelium (CL_0002577)  
• Pulmonary Mucosa  
• Saliva (UBERON_0001836)  
• Trachea (UBERON_0003126)  
• Urine (UBERON_0001088)  
• Uterine Cervix (UBERON_0000002)   HEp-2 (CVCL_1906)  
• C10 (CVCL_5245)  
• CHO (CVCL_0213)  
• COLO 205 (CVCL_0218)  
• Caco-2 (CVCL_0025)  
• Co115 (CVCL_D102)  
• DLD-1 (CVCL_0248)  
• HCT 116 (CVCL_0291)  
• HCT 15 (CVCL_0292)  
• HCT 8 (CVCL_2478)  
• HEK293 (CVCL_0045)  
• HEK293-F (CVCL_6642)  
• HL-60 (CVCL_0002)   Leukocyte (CL_0000738)  
• HT29 (CVCL_A8EZ)  
• KM12 (CVCL_1331)  
• LOVO (CVCL_0399)  
• LS174T (CVCL_1384)  
• LS180 (CVCL_0397)  
• LS411N (CVCL_1385)  
• RKO (CVCL_0504)  
• SW1116 (CVCL_0544)  
• SW1398 (CVCL_3885)  
• SW1463 (CVCL_1718)  
• SW48 (CVCL_1724)  
• SW837 (CVCL_1729)  
• SW948 (CVCL_0632)  
• T84 (CVCL_0555)  
• WiDr (CVCL_2760)  
• Adipocytes (CL_0000136)  
• Adipose-derived stem cells (ADSCs) (CL_0000136)  
• Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)  
• Erythrocyte (CL_0000232)  
• Erythrocyte (CL_0000232)   Plasma Membrane (GO_0005886)  
• Granulocyte (CL_0000094)  
• Leukocyte (CL_0000738)  
• Neutrophil (CL_0000775)  
• Platelet (CL_0000233)   Plasma Membrane (GO_0005886)  
• T-Lymphocyte (CL_0000084)  

Reported structure

• O-Linked / Core 1 / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)[NeuAc(a2-6)]GalNAc
• O-Linked / Core 1 / Structure 10140
• O-Linked / Core 2 / Neu5Ac(?2-?)Gal(?1-?)GlcNAc(?1-?)[Neu5Ac(?2-?)Gal(?1-?)]GalNAc(?1-
• O-Linked / Core 2 / NeuAc(?2-?)Gal(?1-?)GlcNAc(b1-6)[NeuAc(?2-?)Gal(b1-3)]GalNAc
• O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
• O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-?)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
• O-Linked / Core 2 / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
• O-Linked / Core 2 / NeuAc(a2-?)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-?)Gal(b1-3)]GalNAc
• O-Linked / Core 2 / Structure 11060

Composition

• Hex:2 HexNAc:2 NeuAc:2 (avg mass : 1331.2059 )

Disease

• Adenocarcinoma (DOID:299)
• Cancer, breast (DOID:1612)
• Carcinoma, Hepatocellular (DOID:684)
• Cecum adenocarcinoma (DOID:3039)
• Chondrosarcoma (DOID:3371)
• Choriocarcinoma (DOID:3594)
• Colon adenocarcinoma (DOID:234)
• Colon carcinoma (DOID:1520)
• Colorectal carcinoma (DOID:0080199)
• Control/Healthy
• COVID-19 (DOID:0080600)
• Cystic Fibrosis (DOID:1485)
• Hybridoma
• Leukemia, Acute myelogenous (DOID:9119)
• Leukemia, Myloid, Chronic (DOID:8552)
• Leukemia, Promyelocytic (DOID:0060318)
• Lymphoma (DOID:0060058)
• Lysosomal storage disease (DOID:3211)
• Mixed phenotype acute leukemia (DOID:9953)
• Prostate cancer (DOID:10283)
• Rectal adenocarcinoma (DOID:1996)
• Sialidosis (Mucolipidosis I) (DOID:3343)
• Wiskott-Aldrich Syndrome (DOID:9169)

Reference

• Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
• Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. (2021 - Oliveira T, Zhang M, Joo EJ, Abdel-Azim H, Chen CW, Yang L, Chou CH, Qin X, Chen J, Alagesan K, Almeida A, Jacob F, Packer NH, von Itzstein M, Heisterkamp N, Kolarich D) / Status : Reviewed
• Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype (2021 - Katarina Madunić, Tao Zhang, Oleg A Mayboroda, Stephanie Holst, Kathrin Stavenhagen, Chunsheng Jin, Niclas G Karlsson, Guinevere S M Lageveen-Kammeijer, Manfred Wuhrer) / Status : Unreviewed
• Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis (2021 - Rebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, Marshall Bern, Weiqian Cao, Robert J. Chalkley, Kai Cheng, Matthew S. Choo, Nathan Edwards, Radoslav Goldman, Marcus Hoffmann, Yingwei Hu, Yifan Huang, Jin Young Kim, Doron Kletter, Benoit Liquet, Mingqi Liu, Yehia Mechref, Bo Meng, Sriram Neelamegham, Terry Nguyen-Khuong, Jonas Nilsson, Adam Pap, Gun Wook Park, Benjamin L. Parker, Cassandra L. Pegg, Josef M. Penninger, Toan K. Phung, Markus Pioch, Erdmann Rapp, Enes Sakalli, Miloslav Sanda, Benjamin L. Schulz, Nichollas E. Scott, Georgy Sofronov, Johannes Stadlmann, Sergey Y. Vakhrushev, Christina M. Woo, Hung-Yi Wu, Pengyuan Yang, Wantao Ying, Hui Zhang, Yong Zhang, Jingfu Zhao, Joseph Zaia, Stuart M. Haslam, Giuseppe Palmisano, Jong Shin Yoo, Göran Larson, Kai-Hooi Khoo, Katalin F. Medzihradszky, Daniel Kolarich, Nicolle H. Packer, Morten Thaysen-Andersen) / Status : Reviewed
• Bisecting GlcNAc Protein N-Glycosylation Is Characteristic of Human Adipogenesis. (2020 - Katherine Wongtrakul-Kish, Benjamin R Herbert, Nicolle H Packer) / Status : Reviewed
• Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor (2020 - Peng Zhao, Jeremy L. Praissman, Oliver C. Grant, Yongfei Cai, Tianshu Xiao, Katelyn E. Rosenbalm, Kazuhiro Aoki, Benjamin P. Kellman, Robert Bridger, Dan H. Barouch, Melinda A. Brindley, Nathan E. Lewis, Michael Tiemeyer, Bing Chen, Robert J. Woods, Lance Wells) / Status : Reviewed
• Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Reviewed
• Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
• Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3) (2015 - Rosina Plomp, Gillian Dekkers, Yoann Rombouts, Remco Visser, Carolien A.M.Koeleman, Guinevere S.M.Kammeijer, Bas C.Jansen, Theo Rispens, Paul J.Hensbergen, Gestur Vidarsson, Manfred Wuhrer) / Status : Reviewed
• Identification of protein O-glycosylation site and corresponding glycans using liquid chromatography-tandem mass spectrometry via mapping accurate mass and retention time shift (2014 - Huang LJ, Lin JH, Tsai JH, Chu YY, Chen YW, Chen SL, Chen SH) / Status : Reviewed
• Site-specific analysis of the O-glycosylation of bovine fetuin by electron-transfer dissociation mass spectrometry (2014 - Windwarder M, Altmann F) / Status : Reviewed
• Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures (2013 - Strum JS1, Nwosu CC, Hua S, Kronewitter SR, Seipert RR, Bachelor RJ, An HJ, Lebrilla CB) / Status : Reviewed
• Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation. (2002 - Muller S, Hanisch FG) / Status : Reviewed
• In vivo glycosylation of mucin tandem repeats (2001 - Silverman, Parry, Sutton-Smith, Burdick, McDermott, Reid, Batra, Morris, Hollingsworth, Dell, Harris) / Status : Reviewed
• O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme. (2000 - Mattu T, Royle L, Langridge J, Wormald M, Van den Steen P, Van Damme J, Opdenakker G, Harvey D, Dwek R, Rudd P) / Status : Reviewed
• High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. (1999 - Chai W, Yuen C, Kogelberg H, Carruthers R, Margolis R, Feizi T, Lawson A) / Status : Reviewed
• Impaired galactosylation of core 2 O-glycans in erythrocytes of beta1,4-galactosyltransferase knockout mice. (1999 - Kotani N, Asano M, Iwakura Y, Takasaki S) / Status : Reviewed
• Purification and characterization of the MUC1 mucin-type glycoprotein, epitectin, from human urine: structures of the major oligosaccharide alditols. (1998 - Bhavanandan V, Zhu Q, Yamakami K, Dilulio N, Nair S, Capon C, Lemoine J, Fournet B) / Status : Reviewed
• Structural study of the O-linked sugar chains of human leukocyte tyrosine phosphatase CD45. (1998 - Furukawa K, Funakoshi Y, Autero M, Horejsi V, Kobata A, Gahmberg C) / Status : Reviewed
• Structural determination of the O-linked sialyl oligosaccharides liberated from fetuin with endo-alpha-N-acetylgalactosaminidase-S by HPLC analysis and 600-MHz 1H-NMR spectroscopy. (1997 - Ishii-Karakasa I, Iwase H, Hotta K) / Status : Reviewed
• Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells. (1996 - Wilkins P, McEver R, Cummings R) / Status : Reviewed
• Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. (1996 - Lloyd KO, Burchell J, Kudryashov V, Yin BW, Taylor-Papadimitriou J) / Status : Reviewed
• Sialylation and sulfation of the carbohydrate chains in respiratory mucins from a patient with cystic fibrosis. (1994 - Lo-Guidice J, Wieruszeski J, Lemoine J, Verbert A, Roussel P, Lamblin G) / Status : Reviewed
• Structure determination of the disialylated poly-(N-acetyllactosamine)-containing O-linked carbohydrate chains of equine chorionic gonadotropin. (1994 - Hokke C, Roosenboom M, Thomas-Oates J, Kamerling J, Vliegenthart J) / Status : Reviewed
• The carbohydrate chains of the beta subunit of human chorionic gonadotropin produced by the choriocarcinoma cell line BeWo. Novel O-linked and novel bisecting-GlcNAc-containing N-linked carbohydrates. (1992 - Hard K, Damm J, Spruijt M, Bergwerff A, Kamerling J, Van Dedem G, Vliegenthart J) / Status : Reviewed
• Oligosaccharide structures of mucins secreted by the human colonic cancer cell line CL.16E. (1992 - Capon C, Laboisse C, Wieruszeski J, Maoret J, Augeron C, Fournet B) / Status : Reviewed
• 1H and 13C-NMR assignments for sialylated oligosaccharide-alditols related to mucins. Study of thirteen components from hen ovomucin and swallow nest mucin. (1992 - Strecker G, Wieruszeski J, Cuvillier O, Michalski J, Montreuil J) / Status : Reviewed
• Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome. (1991 - Piller F, Le Deist F, Weinberg K, Parkman R, Fukuda M) / Status : Reviewed
• The effect of the carbohydrate moiety upon the size and conformation of human plasma galactoglycoprotein as judged by electron microscopy and circular dichroism. Structural studies of a glycoprotein after stepwise enzymic carbohydrate removal. (1991 - Watzlawick H, Walsh M, Ehrhard I, Slayter H, Haupt H, Schwick H, Jourdian G, Hase S, Schmid K, Brossmer R) / Status : Reviewed
• Structures of acidic O-linked polylactosaminoglycans on human skim milk mucins. (1990 - Hanisch F, Peter-Katalinic J, Egge H, Dabrowski U, Uhlenbruck G) / Status : Reviewed
• Structure determination of the major N- and O-linked carbohydrate chains of the beta subunit from equine chorionic gonadotropin. (1990 - Damm J, Hard K, Kamerling J, van Dedem G, Vliegenthart J) / Status : Reviewed
• Isolation and structural characterization of sialic-acid-containing glycopeptides of the O-glycosidic type from the urine of two patients with an hereditary deficiency in alpha-N-acetylgalactosaminidase activity. (1989 - Linden H, Klein R, Egge H, Peter-Katalinic J, Dabrowski J, Schindler D) / Status : Reviewed
• Structural studies on oncofetal carbohydrate antigens (Ca 19-9, Ca 50, and Ca 125) carried by O-linked sialyloligosaccharides on human amniotic mucins. (1988 - Hanisch F, Uhlenbruck G, Peter-Katalinic J, Egge H) / Status : Reviewed
• Structural analysis by fast-atom-bombardment mass spectrometry of the mixture of alditols derived from the O-linked oligosaccharides of murine glycophorins. (1988 - Krotkiewski H, Lisowska E, Angel A, Nilsson B) / Status : Reviewed
• Comparative study of the mucin-type sugar chains of human chorionic gonadotropin present in the urine of patients with trophoblastic diseases and healthy pregnant women. (1988 - Amano J, Nishimura R, Mochizuki M, Kobata A) / Status : Reviewed
• Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. (1988 - Piller F, Piller V, Fox R, Fukuda M) / Status : Reviewed
• Identification of a tetrasialylated monofucosylated tetraantennary N-linked carbohydrate chain in human platelet glycocalicin. (1988 - Korrel S, Clemetson K, van Halbeek H, Kamerling J, Sixma J, Vliegenthart J) / Status : Reviewed
• Structural analysis of O-glycosidic type of sialyloligosaccharide-alditols derived from urinary glycopeptides of a sialidosis patient. (1988 - van Pelt J, Van Bilsen D, Kamerling J, Vliegenthart J) / Status : Reviewed
• Structures of the sialylated oligosaccharide chains in swine tracheal mucin glycoproteins. (1987 - Rana SS, Chandrasekaran EV, Mendicino J) / Status : Reviewed
• The structures of N- and O-glycosidic carbohydrate chains of a chondroitin sulfate proteoglycan isolated from the media of the human aorta. (1987 - Akiyama F, Stevens R, Hayashi S, Swann D, Binette J, Caterson B, Schmid K, Van Halbeek H, Mutsaers J, Gerwig G) / Status : Reviewed
• Presence of an O-glycosidically linked hexasaccharide in fetuin. (1987 - Edge A, Spiro R) / Status : Reviewed
• Structures of O-linked oligosaccharides present in the proteoglycans secreted by human mammary epithelial cells. (1986 - Gowda D, Bhavanandan V, Davidson E) / Status : Reviewed
• The structure of the O-glycosidic oligosaccharide chains of the major Zajdela hepatoma ascites-cell-membrane glycoprotein. (1986 - Nato F, Goulut C, Bourrillon R, Van Halbeek H, Vliegenthart J) / Status : Reviewed
• Characterization of O-glycosidically linked oligosaccharides of rat erythrocyte membrane sialoglycoproteins. (1986 - Edge A, Van Langenhove A, Reinhold V, Weber P) / Status : Reviewed
• Structures of O-linked oligosaccharides isolated from normal granulocytes, chronic myelogenous leukemia cells, and acute myelogenous leukemia cells. (1986 - Fukuda M, Carlsson S, Klock J, Dell A) / Status : Reviewed
• Structural variations of O-linked oligosaccharides present in leukosialin isolated from erythroid, myeloid, and T-lymphoid cell lines. (1986 - Carlsson S, Sasaki H, Fukuda M) / Status : Reviewed
• Structures of the O-linked oligosaccharides of the major cell surface sialoglycoprotein of MAT-B1 and MAT-C1 ascites sublines of the 13762 rat mammary adenocarcinoma. (1984 - Hull S, Laine R, Kaizu T, Rodriguez I, Carraway K) / Status : Reviewed
• Structural studies on the O-linked carbohydrate chains of human platelet glycocalicin. (1984 - Korrel S, Clemetson K, Van Halbeek H, Kamerling J, Sixma J, Vliegenthart J) / Status : Reviewed
• The structure of the carbohydrate units of human plasma galactoglycoprotein determined by 500-megahertz 1H NMR spectroscopy. (1984 - Akiyama K, Simons E, Bernasconi P, Schmid K, van Halbeek H, Vliegenthart J, Haupt H, Schwick H) / Status : Reviewed
• The carbohydrate moiety of human platelet glycocalicin. (1983 - Tsuji T, Tsunehisa S, Watanabe Y, Yamamoto K, Tohyama H, Osawa T) / Status : Reviewed
• Structure of O-glycosidically linked sugar units from plasma membranes of an ascites hepatoma, AH 66. (1982 - Funakoshi I, Yamashina I) / Status : Reviewed
• Structures of N-linked and O-linked oligosaccharides on proteoglycan monomer isolated from the Swarm rat chondrosarcoma. (1982 - Nilsson B, De Luca S, Lohmander S, Hascall V) / Status : Reviewed
• Oligosaccharides on proteoglycans from the swarm rat chondrosarcoma. (1980 - Lohmander L, De Luca S, Nilsson B, Hascall V, Caputo C, Kimura J, Heinegard D) / Status : Reviewed
• Chemical structure of epiglycanin, the major glycoprotein of the TA3-Ha ascites cell. The carbohydrate chains. (1979 - van den Eijnden D, Evans N, Codington J, Reinhold V, Silber C, Jeanloz R) / Status : Reviewed

Reported glycosite

• Angiotensin-converting enzyme 2 / Homo sapiens
  •        Undefined site
• Chondroitin sulfate proteoglycan / Homo sapiens
  •        Undefined site
• Choriogonadotropin - alpha and beta chains / Homo sapiens
  •        Undefined site
• Choriogonadotropin beta chain / Homo sapiens
  •        Undefined site
• Coagulation factor IX / Homo sapiens
  •        Thr-85
  •        Thr-205
  •        Thr-215
• Glycocalicin / Homo sapiens
  •        Undefined site
• Hemopexin / Homo sapiens
  •        Thr-40
• Immunoglobulin gamma-3 (anti-GDob1 allotype G3m(g) / monoclonal) / Homo sapiens
  •        Thr-122
  •        Thr-137
  •        Thr-152
• Immunoglobulin gamma-3 (anti-GDob1 allotype G3m(s) / monoclonal) / Homo sapiens
  •        Thr-122
  •        Thr-137
  •        Thr-152
• Insulin-like growth factor II / Homo sapiens
  •        Thr-99
• Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
  •        Thr-725
• Leukosialin (cd43) / Homo sapiens
  •        Undefined site
• Matrix metalloproteinase-9 / Homo sapiens
  •        Undefined site
• Muc1 fusion protein / Homo sapiens
  •        Undefined site
• Mucin-1 / Homo sapiens
  •        Undefined site
• P-selectin glycoprotein ligand (psgl-1) / Homo sapiens
  •        Undefined site
• Plasma protease c1 inhibitor / Homo sapiens
  •        Thr-47
• Proheparin-binding EGF-like growth factor / Homo sapiens
  •        Thr-37
• Prostaglandin-h2 d-isomerase / Homo sapiens
  •        Ser-67
  •        Ser-81
• Protein heg homolog 1 / Homo sapiens
  •        Thr-91
• Protein YIPF3 / Homo sapiens
  •        Thr-346
  •        Ser-349
• Proteoglycan / Homo sapiens
  •        Undefined site
• Receptor-type tyrosine-protein phosphatase C / Homo sapiens
  •        Undefined site
• Recombinant Mucin-1 Muc1f (delta tr) / Homo sapiens
  •        Undefined site
• Recombinant Mucin-1 Muc1f/2tr / Homo sapiens
  •        Undefined site
• Recombinant Mucin-1 Muc1f/5actr / Homo sapiens
  •        Undefined site
• Recombinant Mucin-1 Muc1f/5btr / Homo sapiens
  •        Undefined site
• Uncharacterized protein / Homo sapiens
  •        Undefined site
• Uncharacterized protein / Homo sapiens
  •        Undefined site
• Uncharacterized protein from Urine / Homo sapiens
  •        Undefined site
• Unspecified mucin / Homo sapiens
  •        Undefined site
• Urine glycopeptide / Homo sapiens
  •        Undefined site
• Alpha-2-hs-glycoprotein / Bos taurus
  •        Undefined site
  •        Ser-271
  •        Thr-280
  •        Ser-296
• Kappa casein / Bos taurus
  •        Thr-152
  •        Thr-163
• Choriogonadotropin beta chain / Equus caballus
  •        Undefined site
• Epiglycanin / Mus musculus
  •        Undefined site
• Glycophorin / Mus musculus
  •        Undefined site
• Uncharacterized protein / Mus musculus
  •        Undefined site
• Uncharacterized protein / Mus musculus
  •        Undefined site
• Uncharacterized protein / Mus musculus
  •        Undefined site
• Brain non dialyzable glycopeptide / Oryctolagus cuniculus
  •        Undefined site
• Asgp-1 / Rattus norvegicus
  •        Undefined site
• Major membrane glycoprotein - MII2 / Rattus norvegicus
  •        Undefined site
• Sialoglycoprotein (rspg-4) / Rattus norvegicus
  •        Undefined site
• Uncharacterized protein from Liver / Rattus norvegicus
  •        Undefined site
• Uncharacterized proteoglycan / Rattus norvegicus
  •        Undefined site
• Mucin / Sus scrofa
  •        Undefined site
• Mucin / Collocalia sp
  •        Undefined site
• Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
  •        Thr-323
• Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
  •        Thr-323
  •        Ser-325
• Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
  •        Thr-323

Mass spectrometry observed peptide

• GLAAGTSNPDPPTVSTDQLLPLGGGR (26aa)
  •    Q99075    Thr-37     Proheparin-binding EGF-like growth factor / Homo sapiens
• GLAAGTSNPDPPTVSTDQLLPLGGGRDR (28aa)
  •    Q99075    Thr-37     Proheparin-binding EGF-like growth factor / Homo sapiens
• TPLPPTSAHGNVAEGETKPDPDVTER (26aa)
  •    P02790    Thr-40     Hemopexin / Homo sapiens
• VATTVISK (8aa)
  •    P05155    Thr-47     Plasma protease c1 inhibitor / Homo sapiens
• SVVAPATDGGLNLTSTFLRKNQCETR (26aa)
  •    P41222    Ser-81     Prostaglandin-h2 d-isomerase / Homo sapiens
  •    P41222    Ser-67     Prostaglandin-h2 d-isomerase / Homo sapiens
• APEPGAATQR (10aa)
  •    Q9ULI3    Thr-91     Protein heg homolog 1 / Homo sapiens
• DVSTPPTVLPDNFPR (15aa)
  •    P01344    Thr-99     Insulin-like growth factor II / Homo sapiens
• SCDTPPPCPR (10aa)
  •    P01860    Thr-137     Immunoglobulin gamma-3 (anti-GDob1 allotype G3m(s) / monoclonal) / Homo sapiens
  •    P01860    Thr-122     Immunoglobulin gamma-3 (anti-GDob1 allotype G3m(s) / monoclonal) / Homo sapiens
  •    P01860    Thr-152     Immunoglobulin gamma-3 (anti-GDob1 allotype G3m(g) / monoclonal) / Homo sapiens
  •    P01860    Thr-152     Immunoglobulin gamma-3 (anti-GDob1 allotype G3m(s) / monoclonal) / Homo sapiens
  •    P01860    Thr-137     Immunoglobulin gamma-3 (anti-GDob1 allotype G3m(g) / monoclonal) / Homo sapiens
  •    P01860    Thr-122     Immunoglobulin gamma-3 (anti-GDob1 allotype G3m(g) / monoclonal) / Homo sapiens
• VQPTESIVR (9aa)
  •    P0DTC2    Ser-325     Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
  •    P0DTC2    Thr-323     Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
• AVAVTLQSH (9aa)
  •    Q9GZM5    Thr-346     Protein YIPF3 / Homo sapiens
  •    Q9GZM5    Ser-349     Protein YIPF3 / Homo sapiens
• IEETTMTTQTPAPIQAPSAILPLPGQSVER (30aa)
  •    Q14624    Thr-725     Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens